| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059093A2 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 08/16/2001 | WO2001059089A2 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059086A2 Methods and constructs for agrobacterium-mediated plant transformation |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059079A1 UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1 |
| 08/16/2001 | WO2001059076A2 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059069A1 Cell culture media |
| 08/16/2001 | WO2001059068A2 Artificial bone chips, methods for the production thereof and their use |
| 08/16/2001 | WO2001059062A2 Method for obtaining in vitro polarized hepatoma cell lines |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058931A1 Method of treating disorders of the eye |
| 08/16/2001 | WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058526A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | WO2001058477A2 Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/16/2001 | WO2001058463A1 Neuronal cell division |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058460A1 Isolation and transplantation of retinal stem cells |
| 08/16/2001 | WO2001058459A1 Remedies for hepatitis c |
| 08/16/2001 | WO2001058413A1 Method for stimulating hair growth and kit for carrying out said method |
| 08/16/2001 | WO2001058255A1 Chimeric animal containing human blood |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001022978A3 Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
| 08/16/2001 | WO2001012172B1 Treatment of metastatic disease |
| 08/16/2001 | WO2001009347A3 Archaeal replication accessory factors and methods of use |
| 08/16/2001 | WO2001009293A3 Mammalian adhesion protease peptides |
| 08/16/2001 | WO2001009292A3 Sentrin-specific human proteases senp1-3 |
| 08/16/2001 | WO2001009190A3 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001006989A3 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 08/16/2001 | WO2001004354A3 Use of ras inhibitors of inhibiting muscle atrophy |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 08/16/2001 | WO2000039557A9 Devices, methods and systems for collecting material from a breast duct |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | WO2000003025A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | US20010014977 DNA sequence encoding protein for pigment synthesis; modifying color phenotype of plant tissue |
| 08/16/2001 | US20010014674 Wound healing agent |
| 08/16/2001 | US20010014475 Aggregate suitable for implantation comprising an aggregate of cells and biodegradable microcarrier particles; cell microcarrier aggregates are grown in mold shaped to conform to the geometry of the desired body part |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014473 Cells having ability to form extracellular cartilage matrix are brought into a cell space where they settle on a plate in a culture medium for producing extracellular cartilage matrix |
| 08/16/2001 | US20010014471 Antitumor agents |
| 08/16/2001 | US20010014467 Reacting trans-ferulic acid and coenzyme a (CoASH) under trans-ferulate:CoASH ligase enzyme activity, trans-feruloyl SCoA hydratase activity, and 4-hydroxy-3-methoxyphenyl-beta-hydroxypropionyl SCoA cleavage activity; Pseudomonas enzymes |
| 08/16/2001 | US20010014464 Nucleic acid encoding follistatin-3 |
| 08/16/2001 | US20010014458 Human G-protein coupled receptor GPR6sb |
| 08/16/2001 | US20010014333 Hybrid heterodimeric protein hormone and method of using same |
| 08/16/2001 | US20010014332 Modified immunogenic pneumolysin compositions as vaccines |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | US20010014321 Basal medium, essential fatty acid, cholesterol, transferrin in an amount of 120 to 500 mu g/ml or an effective amount of an iron salt, insulin growth factor, wherein medium supports proliferation and differentiation of normal CD34+ cells |
| 08/16/2001 | EP1144661A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | EP1123978A1 A cytochrome P450 gene highly expressed in the incompatible interaction |
| 08/16/2001 | EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 08/16/2001 | EP1123975A1 Three-dimensional cell incubation media and method for incubating cells by using the same |
| 08/16/2001 | EP1123706A1 Neuronal cell division |
| 08/16/2001 | EP1123499A2 Miniaturized cell array methods and apparatus for cell-based screening |
| 08/16/2001 | EP1123407A2 Apomixis conferred by expression of serk interacting proteins |
| 08/16/2001 | EP1123406A1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
| 08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
| 08/16/2001 | EP1123404A2 Materials and methods for the modification of plant cell wall polysaccharides |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123398A2 Molecular pathogenicide mediated plant disease resistance |
| 08/16/2001 | EP1123397A2 G-protein coupled receptors |
| 08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123390A2 Methods and reagents for isolating biologically active peptides |
| 08/16/2001 | EP1123389A1 A method of affinity separation and ligands for use therein |
| 08/16/2001 | EP1123388A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 08/16/2001 | EP1123384A2 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
| 08/16/2001 | EP1123313A2 Methods and compositions for the prevention and treatment of anemia |
| 08/16/2001 | EP1123312A2 Human rna binding proteins |
| 08/16/2001 | EP1123306A1 Inhibitors of platelet activation and recruitment |
| 08/16/2001 | EP1123111A1 Modulation of gene expression by combination therapy |
| 08/16/2001 | EP1123108A1 Isolated peptides which bind to hla-b35 molecules |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123067A2 Cardiovascular components for transplantation and methods of making thereof |
| 08/16/2001 | EP1123004A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 08/16/2001 | EP1007630A4 Natural killer cell lines and methods of use |
| 08/16/2001 | EP0832182B1 Apparatus and method for maintaining and growing biological cells |
| 08/16/2001 | EP0749444B1 Hybrid human/animal factor viii |